$400 Million Triboelectric Energy Harvesting (TENG) Market Analysis & Forecasts 2017-2027
Feb 28, 2017 12:29 pm UTC| Business
Dublin, Feb. 28, 2017 -- Research and Markets has announced the addition of the "Triboelectric Energy Harvesting (TENG) 2017-2027" report to their offering. The report navigates...
Feb 28, 2017 12:05 pm UTC| Business
CAMBRIDGE, Mass., Feb. 28, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
Neuralstem Announces Publication of NSI-189 Preclinical Data in Journal of Cellular Physiology
Feb 28, 2017 12:03 pm UTC| Business
-NSI-189 Showed Durable Functional Recovery in a Rodent Model of Ischemic Stroke- -NSI-189 Promoted Synaptic Remodeling After Stroke- GERMANTOWN, Md., Feb. 28, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a...
Feb 28, 2017 12:01 pm UTC| Business
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US Mithra grants its first exclusive license for its vaginal...
Feb 28, 2017 12:01 pm UTC| Business
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US Mithra grants its first exclusive license for its vaginal...
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update
Feb 28, 2017 12:01 pm UTC| Business
Key updates Major progress in the QR-010 development program for CF with presentation of positive clinical data at North American CF conference in October 2016On track to report data from the ongoing Phase 1b trial of...
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update
Feb 28, 2017 12:01 pm UTC| Business
Key updates Major progress in the QR-010 development program for CF with presentation of positive clinical data at North American CF conference in October 2016On track to report data from the ongoing Phase 1b trial of...